• Home
  • Search Results

Search Results

2527 studies match your search
Open

Metastatic Triple Negative Breast Cancer Study

Are you battling triple-negative breast cancer? If your cancer has come back or spread, and you haven't started treatment yet, you might qualify for a clinical trial testing a new medication. Discover more about this opportunity to find a potentially better treatment option.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female
Study Interest
  • Cancer (Breast)

Young Adult Alcohol Use and Social Media Study

We are conducting two 3 hour in-person workshops with young adults who consume alcohol to support the development of an intervention which uses social medial to address the link between alcohol use and cancer risk.

Age & Gender
  • 18 years ~ 25 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Cancer (Breast, Colorectal, Head and Neck, and 2 more)
  • Substance Use (tobacco, alcohol, opioids, etc)
Visit Location
Not currently enrolling

Weight Loss Study

This study is being done to see if an investigational medication works better than a placebo (dummy medicine) for weight loss.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Obesity
Open

Psoriasis Study

Do you have plaque type psoriasis? You may be able to participate in a research study to find out if an investigational medication (zasocitinib) works better than an already FDA approved medication for psoriasis (deucravacitinib).

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Skin, Hair, and Nails
Open

Leukemia Treatment Study

Have you been diagnosed with Leukemia? Do you have a functioning kidney, liver, and cardiac organ? If so, you may be able to participate in a study on a new drug called LBS-007. We want to find out if it is safe for people with Leukemia. Compensation provided.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Leukemia)
Open

MRD assessment in a diverse population of patients with early-stage breast cancer -DCT

Have you diagnosed with lymph node positive early breast cancer, have received surgery, and have not received any systemic or radiation treatment prior to surgery? If so, you may be able to take part in this clinical trial which seeks to improve the treatment of early-stage breast cancer by examining ctDNA, a biomarker found in the blood that may indicate the presence of disease. This study aims to determine if ctDNA can help doctors personalize therapies leading to more effective treatment plans.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Breast)
Open

Detect-ME

Do you have acid reflux, GERD, or Barrett's Esophagus? Are you having standard of care endoscopies performed? You may be able to participate in a research study testing for Barrett's Esophagus and esophageal cancer. Compensation provided.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Stomach and Esophageal)
  • Stomach, Digestion and Gut Health
Open

An Automated Insulin Delivery System Study for Type 2 Diabetes

Are you currently using insulin to treat type 2 diabetes? Are your blood sugar values still not where your provider wants them to be? If you are willing to use an automated insulin delivery system, involving an insulin pump and a continuous glucose monitor, you may be eligible to participate in a research study to find out if the twiist system can improve glycemic control.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Diabetes
Open

Trial of Trastuzumab Deruxtecan with Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer

Have you been diganosed with epithelial high grade ovarian, fallopian tube or primary peritoneal carcinoma? if so, you may be able to participate in this research study to evaluate if the combination of Trastuzumab Deruxtecan (T-DXd) and Bevacizumab works better than bevacizumab alone for the treatment of your type of cancer.

Age & Gender
  • 18 years ~ 99 years
  • Female
Study Interest
  • Cancer (Ovarian)
  • Women's Health
Open

Spectra Discovery

Big Discoveries Start Small! Looking for Young Explorers to Join Our Screen Time Study Have a child ages 3-8? Spectra Discovery is a one-week research study exploring how wearable devices might track screen time in young children. Your child will wear fake glasses, a shirt clip, and a belt activity counter while using a study-provided tablet. Parents will complete brief daily surveys and device logs. Orientation can happen at home or at our Chapel Hill office. Parents are compensated, and kids receive a special thank-you gift! Help us better understand screen use in children-click to learn more.

Age & Gender
  • 3 years ~ 8 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Child and Teen Health
  • Parents of Children
  • Wellness and Lifestyle
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research